Michael Kraus, MD, FACP
Kraus is the service line chief for IU Health Physicians Kidney Diseases and clinical chief of nephrology at Indiana University School of Medicine. He also serves as the CMO of IU Health Adult Dialysis Services and medical director of IU Health Home Dialysis Program.
In practice since 1985, he is widely published and an internationally recognized invited speaker. He is a leader in the field of Short Daily Home Hemodialysis. He also serves on the Interventional Nephrology Advisory Group for the ASN. He is on the Scientific Advisory Board for NxStage Medical and The Renal Network (serving networks 9, 10 and 4). He is the immediate past president of the National Kidney Foundation of Indiana.
Robert Lockridge, MD
Lockridge is a clinical nephrologist and member of the Lynchburg Nephrology Physicians, clinical associate professor of nephrology, University of Virginia, and medical director UVA Lynchburg Home Dialysis Program. He has practiced community nephrology in Lynchburg, Va., since 1982, and is medical director of the home dialysis program at UVA Lynchburg Dialysis Facility.
He started the nocturnal HHD program, modeled after Dr. Pierratos nocturnal program in Toronto, Canada, in Lynchburg in September 1997. It is the first and largest nocturnal HHD program in the United States.
Lockridge is one of the primary investigators for the FHN Nocturnal Trial sponsored by NIH and CMS. He is on the medical machine advisory board for Renal Solutions, which is now owned by Fresenius.
HDU Pioneer Award for outstanding achievement in the advancement of HHD goes to Northwest Kidney Centers of Seattle, Wash., and NxStage Medical Inc. of Lawrence, Mass. Northwest Kidney Centers, celebrating their 50th anniversary year, was the first dialysis organization in the nation in to provide practical, HHD to patients who would have otherwise died of kidney failure.
They accomplished this beginning in the early 1960s, with limited resources, experimental dialysis machines and no government funding. They proved that through repeated blood cleansing, several times a week, ESRD patients could not only survive for many years, but lead active, productive lives while receiving regular dialysis.